Drug Profile
SCH 412348
Alternative Names: SCH-412348; SCH-58261Latest Information Update: 30 Oct 2009
Price :
$50
*
At a glance
- Originator Schering-Plough
- Class Antiparkinsonians
- Mechanism of Action Adenosine A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease